Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Dongze Pharmaceutical Technology Development is a China-based pharmaceutical research and development company headquartered in Chongqing. The firm specializes in the development of chemical drugs, offering a wide range of technical services including drug synthesis, formulation research, and quality standard establishment. Dongze Pharma is particularly active in the consistency evaluation of generic drugs, helping manufacturers meet modern regulatory standards for bioequivalence and quality. Their expertise covers several major therapeutic areas, including cardiovascular, metabolic, and central nervous system diseases. By providing technology transfer and collaborative R&D services, the company plays a key role in the industrialization of pharmaceutical innovations in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Dongze Pharmaceutical Technology Development.